Global Plastic & Metal Biliary Stents Market Strategic Research Report
By Type: Metal Biliary Stents, Plastic Biliary Stents
By Application: Hospital, Medical Center
Regional Forecast: Asia Pacific, Latin America, MEA, Europe, North America
Key Players: Boston Scientific, Cook Medical, Medtronic, Olympus, W. L. Gore & Associates, M.I.Tech, TaeWoong Medical, Micro-Tech
Overzicht
Scope of the Report
The global Plastic & Metal Biliary Stents market size is predicted to grow from US$ 673 million in 2025 to US$ 997 million in 2032; it is expected to grow at a CAGR of 5.8% from 2026 to 2032.
Plastic & metal biliary stents are implantable medical devices designed to maintain bile duct patency and ensure effective bile drainage in patients with obstructive biliary conditions. Plastic stents provide a cost-effective option for short-term management of benign strictures, postoperative complications, or temporary obstructions, and are preferred when frequent stent replacement is anticipated. Metal stents, on the other hand, offer stronger radial support, larger luminal diameter, and longer patency, making them well-suited for long-term drainage, particularly in malignant biliary obstructions. Plastic & metal biliary stents play a vital role in restoring bile flow, alleviating jaundice, reducing the risk of bile duct infections, and improving overall clinical outcomes, supporting the minimally invasive management of biliary diseases.
In 2024, global sales of plastic & metal biliary stents reached 1,235,890 units, with an average selling price of US$498.0 per unit. The single-line production capacity for plastic biliary stents is approximately 50,000-80,000 units per year, with a gross margin of approximately 40%–60%. The single-line production capacity for metal biliary stents is approximately 8,000-10,000 units per year, with a gross margin of approximately 50%–75%. The plastic & metal biliary stents industry chain encompasses three main segments: raw materials, manufacturing, and clinical applications. The upstream primarily consists of suppliers of medical-grade polyurethane, polyethylene, PTFE, silicone, and other polymer materials, as well as metal materials such as nickel-titanium alloys and stainless steel. This includes key components such as laser cutting equipment, braiding equipment, injection molding machines, coating materials, guidewires, and delivery system components, along with aseptic packaging services. The midstream comprises biliary stent manufacturers, responsible for the extrusion molding and cutting of plastic stents, laser cutting or braiding of metal stents, and the entire production process, including coating, delivery catheter system design, assembly, sterilization, and final packaging. The downstream comprises hospitals and endoscopy centers. Products are mainly used in clinical procedures such as ERCP, EUS-guided drainage, or PTBD to treat malignant biliary obstruction, benign stenosis, and postoperative complications. Demand is driven by factors such as disease burden, hospital procurement mechanisms, and medical insurance policies, thus forming a complete plastic & metal biliary stents value chain.
The market for plastic & metal biliary stents is driven and constrained by multiple factors. On the demand side, growth is fueled by the increasing prevalence of bile duct obstruction, cholangiocarcinoma, pancreatic cancer, and benign strictures, while the widespread adoption of minimally invasive procedures such as ERCP, EUS-guided drainage, and PTBD has increased the clinical utilization of stents. Technological advancements and product upgrades, including self-expanding metal stents and coated stents, have improved durability and clinical efficacy, stimulating demand for high-end products. Coverage under health insurance and centralized hospital procurement further support sales, and improvements in healthcare services in emerging markets expand market potential. On the risk side, biliary stents are implantable medical devices with stringent safety and long-term effectiveness requirements, making product defects potentially subject to recalls. Intense market competition, especially in the plastic stent segment, can compress profit margins. Strict regulatory approval, policy changes, the emergence of alternative clinical technologies, and fluctuations in the prices of nitinol and medical-grade polymers or disruptions in key equipment supply may adversely affect production and sales, creating a market environment characterized by both growth opportunities and inherent risks.
This report presents a comprehensive overview of the global Plastic & Metal Biliary Stents market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.
Segment by Type
- Metal Biliary Stents
- Plastic Biliary Stents
Segment by Feature
- Biodegradable Stent
- Non-biodegradable Stent
Segment by Delivery Method
- ERCP Endoscopic Delivery
- EUS-Guided Drainage Delivery
- PTBD Delivery
Segment by Application
- Hospital
- Medical Center
Who Can Use This Report?
This report is written for decision-makers who need a clear, data-backed view of the global Plastic & Metal Biliary Stents market:
- Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
- Distributors, channel partners and end users in Hospital, Medical Center evaluating demand and sourcing options
- Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
- Government agencies, industry associations and research institutions tracking industry developments and policy impact
Market snapshot
Global Plastic & Metal Biliary Stents Market Strategic Research Report snapshot, 2025–2032
© MarketResearchReports.comDisclaimer: The actual data may vary in the final report which undergoes verification check post order confirmation.Segments covered in this report
Table of contents
01Executive Summary
02Industry Overview & Forecast
- 2.1.1 Market Definition and Scope
- 2.1.2 Market Size and Growth Forecast
- 2.1.3 Volume Analysis
- 2.1.4 Segment Outlook by Type
- 2.1.5 Segment Outlook by Application
- 2.1.6 Regional Outlook
- 2.1.7 Structural Developments Shaping the Forecast
- 2.1.8 Forecast Risks and Sensitivities
03Market Segmentation by Type
- 3.1 Market Segmentation by Type
- 3.1.1 Market by Type Overview
- 3.1.2 Metal Biliary Stents
- 3.1.3 Plastic Biliary Stents
- 3.1.4 Volume Analysis
04Market Segmentation by Application
- 4.1 Market Segmentation by Application
- 4.1.1 Market by Application Overview
- 4.1.2 Hospital
- 4.1.3 Medical Center
- 4.1.4 Volume Analysis
05Regional Market Forecast
- Asia Pacific
- North America
- Europe
- Middle East & Africa
- Latin America
06Country-Level Market Forecast
- 6.1 Asia Pacific
- 6.1.1 China
- 6.1.2 Japan
- 6.1.3 Korea
- 6.1.4 Southeast Asia
- 6.1.5 India
- 6.1.6 Australia
- 6.1.7 Rest of Asia Pacific
- 6.2 North America
- 6.2.1 United States
- 6.2.2 Canada
- 6.2.3 Mexico
- 6.2.4 Rest of North America
- 6.3 Europe
- 6.3.1 Germany
- 6.3.2 France
- 6.3.3 UK
- 6.3.4 Italy
- 6.3.5 Russia
- 6.3.6 Rest of Europe
- 6.4 Middle East & Africa
- 6.4.1 Egypt
- 6.4.2 South Africa
- 6.4.3 Israel
- 6.4.4 Turkey
- 6.4.5 GCC Countries
- 6.4.6 Rest of Middle East & Africa
- 6.5 Latin America
- 6.5.1 Brazil
- 6.5.2 Rest of Latin America
07Growth Drivers & Inhibitors
- 7.1 Growth Drivers & Inhibitors
- 7.1.1 Section Overview
- 7.1.2 Growth Drivers
- 7.1.3 Growth Inhibitors
- 7.1.4 Driver and Inhibitor Impact Assessment
- 7.1.5 Analyst Perspective
08Key Company Profiles
- 8.1 Boston Scientific
- 8.1.1 Company Overview
- 8.1.2 Key Products & Segments
- 8.1.3 Financial Performance (2023–2025)
- 8.1.4 Business Strategy
- 8.1.5 SWOT Analysis
- 8.1.6 Strategic Implications (2026–2032)
- 8.2 Cook Medical
- 8.2.1 Company Overview
- 8.2.2 Key Products & Segments
- 8.2.3 Financial Performance (2023–2025)
- 8.2.4 Business Strategy
- 8.2.5 SWOT Analysis
- 8.2.6 Strategic Implications (2026–2032)
- 8.3 Medtronic
- 8.3.1 Company Overview
- 8.3.2 Key Products & Segments
- 8.3.3 Financial Performance (2023–2025)
- 8.3.4 Business Strategy
- 8.3.5 SWOT Analysis
- 8.3.6 Strategic Implications (2026–2032)
- 8.4 Olympus
- 8.4.1 Company Overview
- 8.4.2 Key Products & Segments
- 8.4.3 Financial Performance (2023–2025)
- 8.4.4 Business Strategy
- 8.4.5 SWOT Analysis
- 8.4.6 Strategic Implications (2026–2032)
- 8.5 W. L. Gore & Associates
- 8.5.1 Company Overview
- 8.5.2 Key Products & Segments
- 8.5.3 Financial Performance (2023–2025)
- 8.5.4 Business Strategy
- 8.5.5 SWOT Analysis
- 8.5.6 Strategic Implications (2026–2032)
- 8.6 M.I.Tech
- 8.6.1 Company Overview
- 8.6.2 Key Products & Segments
- 8.6.3 Financial Performance (2023–2025)
- 8.6.4 Business Strategy
- 8.6.5 SWOT Analysis
- 8.6.6 Strategic Implications (2026–2032)
- 8.7 TaeWoong Medical
- 8.7.1 Company Overview
- 8.7.2 Key Products & Segments
- 8.7.3 Financial Performance (2023–2025)
- 8.7.4 Business Strategy
- 8.7.5 SWOT Analysis
- 8.7.6 Strategic Implications (2026–2032)
- 8.8 Micro-Tech
- 8.8.1 Company Overview
- 8.8.2 Key Products & Segments
- 8.8.3 Financial Performance (2023–2025)
- 8.8.4 Business Strategy
- 8.8.5 SWOT Analysis
- 8.8.6 Strategic Implications (2026–2032)
09Competitive Landscape
- 9.1 Competitive Landscape Overview
- 9.2 Competitive Intensity Assessment
- 9.3 Key Player Strategies & Positioning
- 9.4 Competitive Dynamics & Strategic Outlook
- 9.4.1 Emerging Competitive Threats
- 9.4.2 Consolidation vs. Fragmentation Outlook
- 9.4.3 Competitive Response Matrix
- 9.4.4 Strategic Recommendations, 2026–2032
10Porter's Five Forces Analysis
- 10.1 Threat of New Entrants
- 10.2 Bargaining Power of Buyers
- 10.3 Bargaining Power of Suppliers
- 10.4 Threat of Substitutes
- 10.5 Competitive Rivalry
11PESTLE Analysis
- 11.1 Political
- 11.2 Economic
- 11.3 Social and Demographic
- 11.4 Technological
- 11.5 Legal and Regulatory
- 11.6 Environmental
- 11.7 Strategic Implications of the PESTLE Assessment
12SWOT Analysis
13Future Trends & Outlook
- 13.1 Future Trends & Outlook
- 13.1.1 Trend Summary and Commercial Maturity Assessment
- 13.1.2 Technology and Innovation Trends
- 13.1.3 Long-Term Market Outlook
- 13.1.4 Investment & M&A Activity Outlook
- 13.1.5 Overall Outlook Assessment
Frequently asked questions
What is the size of the global Plastic & Metal Biliary Stents market?
What is the forecast CAGR for the Plastic & Metal Biliary Stents market?
What is Plastic & Metal Biliary Stents?
How is the Plastic & Metal Biliary Stents market segmented by type?
What are the key applications of Plastic & Metal Biliary Stents?
Which companies are profiled in the Plastic & Metal Biliary Stents market report?
What geographies does the Plastic & Metal Biliary Stents market analysis include?
What are the key demand drivers for Plastic & Metal Biliary Stents?
Who should buy the Plastic & Metal Biliary Stents market report?
What license options are available for this report?
Research Methodology
All MarketResearchReports.com strategic research reports follow a rigorous, multi-stage methodology combining AI-assisted data synthesis with expert analyst validation.
Systematic collection from 500+ verified sources including SEC filings, industry databases (Bloomberg, Statista, OECD), regulatory filings, trade publications, patent databases, and company annual reports. AI-assisted extraction identifies relevant data points across 10,000+ documents per report.
Dual-validation approach: bottom-up sizing aggregates segment-level production, consumption, and trade data; top-down sizing cross-validates against macroeconomic indicators and total addressable market estimates. Discrepancies >5% trigger analyst review.
Company profiles built from public financial disclosures, product launches, M&A activity, job postings (as capability proxies), and supply chain mapping. Market share estimates triangulated across revenue, capacity, and shipment data.
CAGR projections use time-series regression on 5-10 years of historical data, adjusted for identified demand drivers (technology adoption curves, regulatory catalysts, demographic shifts) and demand inhibitors (cost barriers, substitution risk). Scenario modeling covers base, optimistic, and conservative cases.
All quantitative outputs reviewed by a domain-specialist analyst before publication. Data triangulation requires minimum 3 independent sources for every key figure. Reports undergo a structured peer review against our 47-point quality checklist covering methodology, data citations, logical consistency, and formatting standards.
On-demand reports are generated at time of purchase, incorporating the most recent available data. Static reports are republished when underlying market conditions shift by >10% from baseline assumptions. Purchasers receive update notifications for 12 months.
Need a customized version?
Get country-, segment- or company-specific intelligence tailored to your exact requirements.
Request custom research →Request a free sample
Receive a sample of Global Plastic & Metal Biliary Stents Market Strategic Research Report before you buy.
Customize This Report
Describe your specific requirements and our analysts will scope and deliver a tailored version.
Request Invoice
We will email a proforma invoice within 24 hours. Report access is granted upon payment confirmation.
Navadhi Market Research · Healthcare & Medical Devices